Bhekisisa: Help us choose a winner

0
One of our reader letters will win a one-year digital subscription to the Mail & Guardian. Help us decide who deserves it.

Why has Gauteng run out of ARVs?

0
Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.

State consolidates HIV treatment

0
New medicine combines ARVs into one pill, making them easier to supply.

Impoverished patients benefit from rejected drug patent

0
After a seven-year battle, India's government has successfully defended its right to reject drug patents if a medicine doesn't deserve one.

Health matters: Let’s Bhekisisa it

0
The M&G's new health journalism centre is ready to make its mark, scrutinise and inform.

Funding crisis looms large

0
HIV counsellors play a vital role in Lesotho's health system, but the money is running out.

Opinion: TB cannot be kept behind bars

0
World TB Day is on March 24: We look at plans to curb the disease's spread – in prisons and beyond.

[From our archives]’Smart drugs’ rife at universities

0
Students are abusing schedule six pills ahead of exams – with the help of their doctors.

Opinion: SA should use Brics membership to strengthen research

0
South Africa has a lot to learn about efficient and effective ways to approach health research and policy, suggests John Ouma-Mugabe.

Health sector cleared for surgery

0
An industry-wide probe into private healthcare seems likely, but stakeholders fear a witch hunt.